Annual CFO:
$198.07M+$71.03M(+55.91%)Summary
- As of today, CORT annual cash from operations is $198.07 million, with the most recent change of +$71.03 million (+55.91%) on December 31, 2024.
- During the last 3 years, CORT annual cash from operations has risen by +$30.18 million (+17.97%).
- CORT annual cash from operations is now at all-time high.
Performance
CORT Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFO:
$54.48M+$10.54M(+23.99%)Summary
- As of today, CORT quarterly cash from operations is $54.48 million, with the most recent change of +$10.54 million (+23.99%) on September 30, 2025.
- Over the past year, CORT quarterly cash from operations has dropped by -$19.35 million (-26.21%).
- CORT quarterly cash from operations is now -26.21% below its all-time high of $73.83 million, reached on September 30, 2024.
Performance
CORT Quarterly Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
$162.85M-$19.35M(-10.62%)Summary
- As of today, CORT TTM cash from operations is $162.85 million, with the most recent change of -$19.35 million (-10.62%) on September 30, 2025.
- Over the past year, CORT TTM cash from operations has increased by +$18.19 million (+12.58%).
- CORT TTM cash from operations is now -17.78% below its all-time high of $198.07 million, reached on December 31, 2024.
Performance
CORT TTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
CORT Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +55.9% | -26.2% | +12.6% |
| 3Y3 Years | +18.0% | +61.9% | +19.4% |
| 5Y5 Years | +45.5% | +79.0% | -1.5% |
CORT Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +64.6% | -26.2% | +962.4% | -17.8% | +46.7% |
| 5Y | 5-Year | at high | +64.6% | -26.2% | +962.4% | -17.8% | +46.7% |
| All-Time | All-Time | at high | +634.5% | -26.2% | +571.5% | -17.8% | +520.1% |
CORT Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $54.48M(+24.0%) | $162.85M(-10.6%) |
| Jun 2025 | - | $43.94M(+756.8%) | $182.20M(+1.5%) |
| Mar 2025 | - | $5.13M(-91.4%) | $179.44M(-9.4%) |
| Dec 2024 | $198.07M(+55.9%) | $59.30M(-19.7%) | $198.07M(+36.9%) |
| Sep 2024 | - | $73.83M(+79.3%) | $144.65M(+16.9%) |
| Jun 2024 | - | $41.18M(+73.4%) | $123.73M(-0.9%) |
| Mar 2024 | - | $23.76M(+303.5%) | $124.84M(-1.7%) |
| Dec 2023 | $127.04M(+5.6%) | $5.89M(-88.9%) | $127.04M(-17.8%) |
| Sep 2023 | - | $52.91M(+25.1%) | $154.54M(+14.2%) |
| Jun 2023 | - | $42.29M(+62.9%) | $135.28M(+21.8%) |
| Mar 2023 | - | $25.96M(-22.3%) | $111.03M(-7.7%) |
| Dec 2022 | $120.32M(-28.3%) | $33.39M(-0.8%) | $120.32M(-11.8%) |
| Sep 2022 | - | $33.65M(+86.5%) | $136.36M(-9.9%) |
| Jun 2022 | - | $18.04M(-48.8%) | $151.42M(-14.8%) |
| Mar 2022 | - | $35.25M(-28.7%) | $177.72M(+5.9%) |
| Dec 2021 | $167.89M(+10.5%) | $49.43M(+1.5%) | $167.89M(+9.4%) |
| Sep 2021 | - | $48.70M(+9.8%) | $153.54M(+13.5%) |
| Jun 2021 | - | $44.34M(+74.4%) | $135.28M(-6.1%) |
| Mar 2021 | - | $25.42M(-27.5%) | $144.12M(-5.2%) |
| Dec 2020 | $151.97M(+11.6%) | $35.07M(+15.2%) | $151.97M(-8.1%) |
| Sep 2020 | - | $30.44M(-42.8%) | $165.35M(-4.6%) |
| Jun 2020 | - | $53.19M(+59.9%) | $173.34M(+19.0%) |
| Mar 2020 | - | $33.27M(-31.3%) | $145.71M(+7.0%) |
| Dec 2019 | $136.12M(+17.7%) | $48.45M(+26.1%) | $136.12M(+24.7%) |
| Sep 2019 | - | $38.43M(+50.4%) | $109.18M(-5.3%) |
| Jun 2019 | - | $25.55M(+7.9%) | $115.26M(+9.9%) |
| Mar 2019 | - | $23.68M(+10.0%) | $104.92M(-9.3%) |
| Dec 2018 | $115.67M(+89.8%) | $21.52M(-51.6%) | $115.67M(-2.8%) |
| Sep 2018 | - | $44.51M(+192.6%) | $119.03M(+39.3%) |
| Jun 2018 | - | $15.21M(-55.8%) | $85.45M(-0.4%) |
| Mar 2018 | - | $34.43M(+38.4%) | $85.80M(+40.8%) |
| Dec 2017 | $60.94M(+231.3%) | $24.88M(+127.8%) | $60.94M(+50.0%) |
| Sep 2017 | - | $10.93M(-29.8%) | $40.62M(+5.2%) |
| Jun 2017 | - | $15.57M(+62.8%) | $38.63M(+56.7%) |
| Mar 2017 | - | $9.56M(+109.3%) | $24.66M(+34.1%) |
| Dec 2016 | $18.39M(+487.6%) | $4.57M(-48.9%) | $18.39M(+33.1%) |
| Sep 2016 | - | $8.94M(+461.9%) | $13.82M(+139.5%) |
| Jun 2016 | - | $1.59M(-51.8%) | $5.77M(+42.8%) |
| Mar 2016 | - | $3.30M(+273.4%) | $4.04M(+265.9%) |
| Dec 2015 | $3.13M(+111.4%) | - | - |
| Sep 2015 | - | $883.00K(+735.3%) | -$2.44M(+73.7%) |
| Jun 2015 | - | -$139.00K(+92.2%) | -$9.25M(+48.9%) |
| Mar 2015 | - | -$1.78M(-26.7%) | -$18.09M(+33.9%) |
| Dec 2014 | -$27.38M | -$1.40M(+76.3%) | -$27.38M(+18.6%) |
| Sep 2014 | - | -$5.93M(+34.0%) | -$33.64M(+7.4%) |
| Jun 2014 | - | -$8.98M(+18.8%) | -$36.31M(+0.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2014 | - | -$11.06M(-44.3%) | -$36.56M(+1.3%) |
| Dec 2013 | -$37.06M(-2.9%) | -$7.67M(+10.9%) | -$37.06M(+2.8%) |
| Sep 2013 | - | -$8.60M(+6.9%) | -$38.13M(+1.6%) |
| Jun 2013 | - | -$9.24M(+20.1%) | -$38.76M(-3.6%) |
| Mar 2013 | - | -$11.55M(-32.2%) | -$37.42M(-3.9%) |
| Dec 2012 | -$36.02M(-31.5%) | -$8.74M(+5.3%) | -$36.02M(-7.3%) |
| Sep 2012 | - | -$9.23M(-16.9%) | -$33.57M(-8.5%) |
| Jun 2012 | - | -$7.89M(+22.3%) | -$30.95M(-2.3%) |
| Mar 2012 | - | -$10.16M(-61.4%) | -$30.26M(-10.4%) |
| Dec 2011 | -$27.40M(-23.0%) | -$6.29M(+4.7%) | -$27.40M(-3.2%) |
| Sep 2011 | - | -$6.60M(+8.4%) | -$26.56M(-0.7%) |
| Jun 2011 | - | -$7.21M(+1.2%) | -$26.38M(-11.4%) |
| Mar 2011 | - | -$7.29M(-33.7%) | -$23.69M(-6.3%) |
| Dec 2010 | -$22.29M(-24.0%) | -$5.46M(+15.1%) | -$22.29M(-5.1%) |
| Sep 2010 | - | -$6.43M(-42.3%) | -$21.21M(-14.6%) |
| Jun 2010 | - | -$4.52M(+23.3%) | -$18.51M(+8.3%) |
| Mar 2010 | - | -$5.89M(-34.4%) | -$20.19M(-12.4%) |
| Dec 2009 | -$17.97M(+2.1%) | -$4.38M(-17.5%) | -$17.97M(+0.6%) |
| Sep 2009 | - | -$3.73M(+39.8%) | -$18.08M(+1.2%) |
| Jun 2009 | - | -$6.20M(-69.1%) | -$18.30M(-4.3%) |
| Mar 2009 | - | -$3.66M(+18.5%) | -$17.56M(+4.4%) |
| Dec 2008 | -$18.36M(-67.5%) | -$4.49M(-13.7%) | -$18.36M(-7.5%) |
| Sep 2008 | - | -$3.95M(+27.5%) | -$17.09M(-17.9%) |
| Jun 2008 | - | -$5.45M(-21.9%) | -$14.50M(-22.7%) |
| Mar 2008 | - | -$4.47M(-38.8%) | -$11.81M(-7.7%) |
| Dec 2007 | -$10.96M(+52.8%) | -$3.22M(-135.9%) | -$10.96M(+17.5%) |
| Sep 2007 | - | -$1.36M(+50.6%) | -$13.29M(+23.6%) |
| Jun 2007 | - | -$2.76M(+23.8%) | -$17.39M(+17.8%) |
| Mar 2007 | - | -$3.62M(+34.7%) | -$21.15M(+9.0%) |
| Dec 2006 | -$23.24M(-34.8%) | -$5.54M(-1.5%) | -$23.24M(-8.2%) |
| Sep 2006 | - | -$5.46M(+16.3%) | -$21.47M(-11.0%) |
| Jun 2006 | - | -$6.52M(-14.2%) | -$19.35M(-12.3%) |
| Mar 2006 | - | -$5.71M(-51.2%) | -$17.23M(+0.0%) |
| Dec 2005 | -$17.23M(-25.6%) | -$3.78M(-13.2%) | -$17.23M(+6.1%) |
| Sep 2005 | - | -$3.34M(+24.2%) | -$18.36M(+0.6%) |
| Jun 2005 | - | -$4.40M(+23.0%) | -$18.46M(-7.3%) |
| Mar 2005 | - | -$5.71M(-16.6%) | -$17.21M(-25.4%) |
| Dec 2004 | -$13.72M(-37.1%) | -$4.90M(-42.5%) | -$13.72M(-32.6%) |
| Sep 2004 | - | -$3.44M(-9.2%) | -$10.34M(-17.3%) |
| Jun 2004 | - | -$3.15M(-41.7%) | -$8.82M(+3.6%) |
| Mar 2004 | - | -$2.22M(-45.6%) | -$9.14M(+8.6%) |
| Dec 2003 | -$10.00M(+24.4%) | -$1.53M(+20.1%) | -$10.00M(-18.0%) |
| Sep 2003 | - | -$1.91M(+45.0%) | -$8.47M(-29.1%) |
| Jun 2003 | - | -$3.48M(-12.7%) | -$6.56M(-112.7%) |
| Mar 2003 | - | -$3.09M | -$3.09M |
| Dec 2002 | -$13.23M | - | - |
FAQ
- What is Corcept Therapeutics Incorporated annual cash from operations?
- What is the all-time high annual cash from operations for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated annual cash from operations year-on-year change?
- What is Corcept Therapeutics Incorporated quarterly cash from operations?
- What is the all-time high quarterly cash from operations for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated quarterly cash from operations year-on-year change?
- What is Corcept Therapeutics Incorporated TTM cash from operations?
- What is the all-time high TTM cash from operations for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated TTM cash from operations year-on-year change?
What is Corcept Therapeutics Incorporated annual cash from operations?
The current annual cash from operations of CORT is $198.07M
What is the all-time high annual cash from operations for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high annual cash from operations is $198.07M
What is Corcept Therapeutics Incorporated annual cash from operations year-on-year change?
Over the past year, CORT annual cash from operations has changed by +$71.03M (+55.91%)
What is Corcept Therapeutics Incorporated quarterly cash from operations?
The current quarterly cash from operations of CORT is $54.48M
What is the all-time high quarterly cash from operations for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high quarterly cash from operations is $73.83M
What is Corcept Therapeutics Incorporated quarterly cash from operations year-on-year change?
Over the past year, CORT quarterly cash from operations has changed by -$19.35M (-26.21%)
What is Corcept Therapeutics Incorporated TTM cash from operations?
The current TTM cash from operations of CORT is $162.85M
What is the all-time high TTM cash from operations for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high TTM cash from operations is $198.07M
What is Corcept Therapeutics Incorporated TTM cash from operations year-on-year change?
Over the past year, CORT TTM cash from operations has changed by +$18.19M (+12.58%)